| Prev Close | 179.65 |
| Day Low/High | 174.13 / 179.86 |
| 52 Wk Low/High | 150.37 / 214.48 |
| Avg Volume | 1.08M |
Constellation Brands Inc. (STZ)
174.89
NYSE : Consumer Non-Durables
| Exchange | NYSE |
| Shares Outstanding | 167.50M |
| Market Cap | 34.45B |
| EPS | 18.20 |
| P/E Ratio | 46.66 |
| Div & Yield | 3.00 (1.63%) |
Latest News
Snacks, Sodas and Sweets: 5 Food & Beverages Stocks That Are Buys
Top picks include blue chips and under-the-radar names.
Break In!
Break in. David Klein, Constellation Brands' Executive Vice President and CFO, is becoming Chairman of the Board of Directors of Canopy Growth. I view this move as a strong commitment from STZ and a positive for Canopy Growth shares.
At What Price Do You Own Canopy Growth?
Why I'm leaning toward a trade in the former cannabis darling.
Constellation Brands Could Retest Late May Nadir as Charts Lack Spirit
The producer of alcoholic beverages offers mixed technical signals, though trading volume in the shares has been diminishing this year.
The Stars Line Up Against Equity Markets, My Defensive Posture: Market Recon
There is also reason to see longer-term equity strength in valuations.
Analysts Puffed, Now Passing on Canopy Growth
What is the green swan that will bring buyers back to cannabis companies?
Kass: Time to Buy Cannabis Stocks for a Trade -- And Soon for a LT Investment
I'm considering establishing a long investment stake in a package of cannabis stocks, with emphasis on U.S.-based companies.
Time to Buy Cannabis Stocks (for a Trade)… and Soon for a Long Term Investment
* CGC could trade up to over $30 on the successful House vote passage of the SAFE Banking Act announced last evening * While the short term may remain rocky (pot stocks are down by nearly 50% since April), investors with longer term timeframes shoul...
The Charts of Canopy Growth Are Missing Signs of Accumulation for Now
Let's go to the charts and indicators.
My Problem Children
* "Everyone" has them Over the last few days I have been working on three problem children -- Macy's , Kraft Heinz and Canopy Growth . Though I have still not completed my analysis (all three companies face substantive competitive and business chall...
Morningstar High on Pot Growth, Sees U.S. Going Legal by 2023
Analysts say nation will turn a new leaf, changing federal law within a few years, as cannabis industry expected to grow big time over next decade.
Constellation Brands Is Looking Better but I Have a Fear of Commitment
Let's examine the latest charts and indicators.
Would You Rather Have an Executive Team Managing the Company or the Stock Price?
It all comes down to matching my time frame.
Constellation Brands: I Like the Beer a Lot More Than I Like the Stock
I'm only considering selling the puts. The dividend is not that attractive.
Constellation Brands Could Trade Sideways - Watch the OBV Line for Bullish Clues
Let's see if we can identify the next sustained move.
Constellation Brands Remains Beer Dependent as it Transforms Itself
Changes will come as they move their wine and spirits business to the 'high end', and develop the activities of Canopy Growth, which promises cannabis-infused drinks.
June Rotations and Why I Like Apple on Jony Ive's Departure: Market Recon
The risk is that the chief design officer's departure will cause technical issues in Apple's chart.
Constellation Brands Looking Wobbly as Beer Demand Fizzles
Get defensive on the beverage company.
3 Big Earnings Reports to Watch This Week
Some key names are set to release their latest earnings results.
At Canopy Growth it's a Question of Expansion vs. Value
Canopy Growth's latest financial results offer a reality check.
Should Investors Buy the Dip in Canopy Growth Stock?
Canopy's earnings losses could just be a stepping stone to becoming the industry leader.
Burn Out
I just wrote a piece for Real Money covering fourth-quarter earnings for Canopy Growth , the name most analysts refer to as the top cannabis play in Canada. As you have likely seen by now, the company's operational loss for the quarter printed ugly...
Canopy Growth's Latest Results Can Be Wrapped Up in One Word: Ugly
The cannabis company's performance as outlined in its year-end report should not inspire investor confidence.
Canopy Growth Slips as Production, Margins Disappoint
While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.
Best and Worst Beer Stocks
Wetting my whistle with these 2 beer names, plus 2 stocks to avoid.
